Dunad Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
245 Main St, Cambridge, Massachusetts, 0...Website
www.dunadtx.comRevenue
<$5 MillionIndustry
About Dunad Therapeutics
Dunad Therapeutics is a transatlantic biotech company that leverages proprietary tunable covalent chemistry and deep disease biology insights to develop transformative medicines targeting neurodegenerative diseases such as ALS and Parkinson's Disease. With teams in Cambridge (UK) and Boston (US), the company is dedicated to creating therapies that address urgent unmet medical needs for patients and their families. Their innovative discovery platform focuses on designing selective, long-acting compounds that aim to improve patient outcomes and quality of life. Dunad Therapeutics is committed to pioneering a new generation of medicines that shift the treatment paradigm from palliative care to proactive disease management.Explore more
Dunad Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Dunad Therapeutics
Compare insights from companies similar to Dunad Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Dunad Therapeutics Tech Stack
A closer look at the technologies used by Dunad Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dunad Therapeutics
Sign Up For FreeTo access detailed company insights
Dunad Therapeutics is a transatlantic biotech company that leverages proprietary tunable covalent chemistry and deep disease biology insights to develop transformative medicines targeting neurodegenerative diseases such as ALS and Parkinson's Disease. With teams in Cambridge (UK) and Boston (US), the company is dedicated to creating therapies that... Read More
